“Financial information has a much shorter lifespan and value than clinical information. Blood type and lab results will never change. If you are held ransom for a credit card number, you can simply call and get a new number. But if you are a C-level executive who’s been diagnosed with a new form of cancer, that type of information could have a significant impact on stock performance or the valuation of a global enterprise.”
Dave Baumgartner – Executive VP, Security, Technology & Managed Solutions & Managed Solutions Leader at Mandiant
Source: FireEye
About Dave Baumgartner:
Dave Baumgartner works as an Executive VP, Security, Technology & Managed Solutions & Managed Solutions Leader at Mandiant. They are part of the Information Security team within the Information Technology Department and their management level is VP-Level.
He worked as EVP and Chief Information Officer, Chief Information Officer and Global CTO, and CTO, Americas in a 4-year period.
At Target, Baumgartner was responsible for Cyber Threat Intelligence, Threat Defense Operations, CSIRT, and Vulnerability Management for one of the largest retailers in the United States.
Prior to Target, he was a Managing Director of Consulting Services at Mandiant, responsible for the firm’s strategic consulting business, including strategic program development and SOC/CIRT transformation. Before Mandiant, he was a senior manager in Ernst & Young’s information security practice, focused on security operations and risk management. He has also worked at Best Buy and KPMG in various security and IT roles.
Dave graduated from The University of Texas at San Antonio in 2006 and is currently based in Houston, United States.